Watchers | 6,126 |
52-Wk Low | $45.50 |
52-Wk High | $84.89 |
Market Cap | $6.86B |
Volume | 783,425.00 |
52-Wk High | $84.89 |
52-Wk Low | $45.50 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Intra-Cellular Therapies Inc market cap is $6.86B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Intra-Cellular Therapies Inc 52 week high is $84.89 as of May 20, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Intra-Cellular Therapies Inc 52 week low is $45.50 as of May 20, 2024.
Intra-Cellular Therapies Inc stock price today is $65.00.
Intra-Cellular Therapies Inc stock price yesterday was $66.53.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Intra-Cellular Therapies Inc’s P/E ratio is -56.40.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Intra-Cellular Therapies Inc P/B ratio is 10.5689.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Intra-Cellular Therapies Inc's EBITDA is -47.50.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Intra-Cellular Therapies Inc 50-day moving average is $68.71.
Intra-Cellular Therapies Inc has 610 employees.